A Phase II Trial of Immunotherapy Combined With Neoadjuvant Chemoradiotherapy in Microsatellite Instability-High Locally Advanced Rectal Cancer
Latest Information Update: 05 Jan 2023
At a glance
- Drugs Capecitabine (Primary) ; Irinotecan; Oxaliplatin; Programmed cell death 1 receptor modulators
- Indications Adenocarcinoma; Rectal cancer
- Focus Therapeutic Use
Most Recent Events
- 03 Jun 2020 New trial record